Abstract: The present disclosure provides a remote controller and a health detection system. The remote controller includes a main body, a display module, and a health detection module arranged on the main body. The health detection module is configured to detect a health value of a user, and the health value at least includes a heart rate. The display module is connected to the health detection module and configured to display the health value.

Abstract: A blind guiding apparatus comprises a first wearable assembly on which a voice recognition unit, a central processing unit, a GPS unit, a voice output unit and a Braille display unit are disposed. The blind guiding apparatus provides real-time positioning and navigating functions for a blind user walking outside, wherein the Braille display unit allows the user to confirm a destination address recognized by the voice recognition unit so as to avoid error in navigation.

Abstract: A patient appointment schedule is generated for an open access time window (typically a single day). A no show likelihood is assigned for each time slot based on past patient no show (missed appointment) information, and time slots whose no show likelihood exceeds a threshold are designated as open access time slots. The patient appointment schedule is displayed. During scheduling, an unfilled time slot may be allocated to a patient so as to be converted to a tilled time slot, or conversely a filled time slot may be deallocated so that the filled time slot is converted to an unfilled time slot. However, unfilled open access time slots are allocated to patients only during the open access time window, so as to accommodate patients who should be seen on the same day they call.

Abstract: A method 200 for creating a human resources plan for a hospital system is provided. At Step 202, one or more inputs 46, 48, 50 related to one or more health care services that are each associated with at least one of hospital data and target data are received. At Step 204, variations of the one or more inputs 46, 48, 50 are simulated. At Step 206, the one or more inputs 46, 48, 50 are optimized from the simulated input variations. At Step 208, one or more output human resource plans 78 are created from the optimized inputs.

Abstract: The present disclosure provides an apparatus and method for detecting baby urination, which relate to the field of baby care, and are used to reduce the complexity of the urination detection process. The apparatus comprises: an image collection module configured to collect a baby image; a signal processor connected to the image collection module and configured to acquire the baby image collected by the image collection module, extract baby action features from the baby image, and judge whether a baby urination event occurs according to the baby action features; and a urination event notification module connected to the signal processor and configured to transmit a notification when the signal processor judges that a baby urination event occurs. The present disclosure is applied to the urination detection technology.

Abstract: A medical information system (1) includes a user interface unit (2), a function predictor (6), a visualization unit (8), and a display device (12). The user interface unit (2) receives responses of a patient diagnosed with a disease to standardized questions pertaining to body functions of the diagnosed patient. The function predictor (6) computes predicted function values for the at least one body function based on the received responses, a disease profile, a treatment option, and a statistical model constructed from population based survey results. The visualization unit (8) constructs a visual display of the predicted values of the at least one body function for the diagnosed patient. The display device (12) displays the visual display.

Abstract: A system (50) and method (100) translates quantitative personalized decision content to natural language. Quantitative personalized decision content for a patient is received. The quantitative personalized decision content includes quantitative outcomes of treatment options. Contributing factors for the quantitative outcomes are determined. The treatment options are ranked based on a quantitative measure of the quantitative outcomes. Natural language explanations are presented to the patient describing the most highly ranked treatment option in terms of the contributing factors.

Abstract: A dual band color filter includes a periodic arrangement of metallic dots in a middle transparent medium, having an index of refraction, interposed between a first and a second transparent medium, each having an index of refraction greater than the middle transparent medium index of refraction. The filter accepts visible spectrum light. In response to the periodic arrangement of metallic dots, a surface plasmon mode is generated. In response to a diameter common to all the metallic dots, a local mode is generated, and in response to the combination of the middle, first, and second transparent medium indices of refraction, a waveguide mode is generated. As a result, two distinct wavelength bands of visible spectrum light are transmitted through the bottom surface of the dual band color filter, while attenuating one wavelength band of visible spectrum light.

Abstract: The present description relates to an inhibitory RNA molecule, comprising an oligonucleotide that selectively knocks down expression of either Nanog or a Nanog pseudogene, a vector capable of encoding such inhibitory RNA molecule, pharmaceutical compositions comprising said vector, and methods of treating cancer by administration of said pharmaceutical composition.

Abstract: A system (10) for personalization of patient pathways and treatment options includes a patient information database (32) which stores patient data relating to a patient's medical records. A patient personalization system (12) receives the patient's life-style values and preferences and evaluates choices of pathways and treatments and a clinical decision support system (18) generates choices of pathways and treatments from the patient data and the patient's lifestyle values and preferences.

Abstract: A dual hand color filter includes a periodic arrangement of metallic dots in a middle transparent medium, having index of refraction, interposed between a first and a second transparent medium, each having an index of refraction greater than the middle transparent medium index of refraction. The filter accepts visible spectrum light. In response to the periodic arrangement of metallic dots, a surface plasmon mode is generated. In response to a diameter common to all the metallic dots, a local mode is generated, and in response to the combination of the middle, first, and second transparent medium indices of refraction, a waveguide mode is generated. As a result, two distinct wavelength hands of visible spectrum light are transmitted through the bottom surface of the dual band color filter, while attenuating one wavelength band of visible spectrum light.

Abstract: A method is provided for fabricating an organic light emitting device (OLED) with a spherical back mirror. The method forms a spherical curvature in the substrate and deposits a metal film overlying the spherical curvature, forming a spherical back mirror. A transparent isolation layer is formed overlying the spherical back mirror having a planar top surface. A transparent first electrode layer is formed overlying the isolation layer, and a transparent second electrode layer is formed overlying the first electrode layer. A stack is interposed between the first and second electrode layers. The stack is made up of an electron transport layer adjacent the cathode, a light-emitting (electron injection) layer adjacent to the electron transport layer, a hole transport layer adjacent to the light-emitting layer, and a hole injection layer adjacent to the hole transport layer. The order of the stack layering is dependent which electrode is the anode.

Abstract: Exemplary embodiments enable determination of spatial proximity between two or more features in biological tissue. An exemplary method includes identifying a morphological feature in an image of the biological tissue based on expression levels of a first biomarker indicative of the morphological feature, and receiving a result of a segmentation analysis performed on the image of the biological tissue identifying a set of morphological units in the image external to the morphological feature. An exemplary method includes determining an expression level of a second biomarker corresponding to each unit in the set of morphological units in the image of the biological tissue, and determining a spatial distance between the morphological feature and each unit in the set of morphological units.

Abstract: The present description relates to an inhibitory RNA molecule, comprising an oligonucleotide that selectively knocks down expression of either Nanog or a Nanog pseudogene, a vector capable of encoding such inhibitory RNA molecule, pharmaceutical compositions comprising said vector, and methods of treating cancer by administration of said pharmaceutical composition.

Abstract: A method is provided for fabricating an organic light emitting device (OLED) with a spherical back mirror. The method forms a spherical curvature in the substrate and deposits a metal film overlying the spherical curvature, forming a spherical back mirror. A transparent isolation layer is formed overlying the spherical back mirror having a planar top surface. A transparent first electrode layer is formed overlying the isolation layer, and a transparent second electrode layer is formed overlying the first electrode layer. A stack is interposed between the first and second electrode layers. The stack is made up of an electron transport layer adjacent the cathode, a light-emitting (electron injection) layer adjacent to the electron transport layer, a hole transport layer adjacent to the light-emitting layer, and a hole injection layer adjacent to the hole transport layer. The order of the stack layering is dependent which electrode is the anode.

Abstract: Exemplary embodiments enable determination of spatial proximity between two or more features in biological tissue. An exemplary method includes identifying a morphological feature in an image of the biological tissue based on expression levels of a first biomarker indicative of the morphological feature, and receiving a result of a segmentation analysis performed on the image of the biological tissue identifying a set of morphological units in the image external to the morphological feature. An exemplary method includes determining an expression level of a second biomarker corresponding to each unit in the set of morphological units in the image of the biological tissue, and determining a spatial distance between the morphological feature and each unit in the set of morphological units.

Abstract: A Multiform Suspension Microgranular Bioreactor (MSMB) is used to detect nucleic acids or peptides/proteins in molecular and biological samples. Polymer-based microgranules, coupled with biomass molecule probes, are constructed with different features. The biomass molecule probes include cDNA probes, oligonucleic acid probes, peptide or protein probes. These microgranules are differentiated according to their features including shape, size, color, fluorescence intensity, magnetic property, gravity, chemical luminal intensity, radioactivity, and other labels. The above microgranules are suspended in a sample solution and are used collectively as a microarray-like bioreactor device. Such MSMB-based microarrays are particularly useful in complicated biological detection assays with flow cytometry.